Overview
- Legal name
- KEMP PROTEINS, LLC
- Registered location
- FREDERICK, MD, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Jan 15, 2026
Read company summary
KEMP PROTEINS, LLC is associated with UEI JMLEB78WL8B4 and CAGE 5BCT2 in public federal records. AcornBids currently links 2 prime awards totaling $46.4K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Biological Product (except Diagnostic) Manufacturing; Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists FREDERICK, MD, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 5, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- KEMP PROTEINS, LLC
- UEI
- JMLEB78WL8B4
- CAGE
- 5BCT2
- Registered address
- 5119 PEGASUS CT, FREDERICK, MD, 21704, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jun 15, 2026
- Initial registration
- Oct 28, 2019
- Entity start
- Jan 2, 2019
- SAM updated
- Jun 15, 2026
- Registration expires
- Jun 11, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 2 awards and $46,392 in reported obligations to this legal entity. Source
- Recorded awards include Biological Product (except Diagnostic) Manufacturing (NAICS 325414); this classification is not proof of every company capability. Source
- An example award describes: HYBRIDOMA PRODUCTION Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 2 of 2 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $0 |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $33.6K |
| Change | $-33.6K |
| Growth | -100.0% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Defense | $40.0K | 1 |
| Department of Health and Human Services | $-6.4K | 1 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| DEFENSE HEALTH AGENCY | $40.0K | 1 |
| FDA OFFICE OF ACQ GRANT SVCS | $-6.4K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | $40.0K | 1 |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $-6.4K | 1 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $40.0K | 1 |
| AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $-6.4K | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| HT942525D0002 | $40.0K | 1 |
| Unclassified | $-6.4K | 1 |
States
| Category | Period obligations | Awards |
|---|---|---|
| MD | $33.6K | 2 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $40.0K | 1 |
| NO SET ASIDE USED. | $-6.4K | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HT942525FE003HYBRIDOMA PRODUCTION | Department of Defense | $40.0K | Aug 1, 2025 | Jul 31, 2026 |
| 75F40121P00578BACULOVIRUS PROTEIN EXPRESSION | Department of Health and Human Services | $6.4K | Sep 13, 2021 | Sep 12, 2022 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jun 15, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Oct 28, 2019 |
| Entity start | Jan 2, 2019 |
Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MIKE KEEFE | Government business | Contact method not published | SAM registration | Not available |
| MIKE KEEFE | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 325414 — Biological Product (except Diagnostic) Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registered products and services
- 6509 — Drugs and Biologicals, Veterinary Use.
- AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit